de Groot-Kruseman HA - Search Results

1

Upregulated transforming growth factor-beta 1 mRNA expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation.

de Groot-Kruseman HA, Baan CC, Mol WM, Niesters HG, Maat AP, Balk AH, Weimar W. de Groot-Kruseman HA, et al. Transplant Proc. 1999 Nov;31(7):2724-5. doi: 10.1016/s0041-1345(99)00540-0. Transplant Proc. 1999. PMID: 10578265 No abstract available.

2

Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial.

Thus KA, De Groot-Kruseman HA, Winkler-Seinstra P, Fiocco M, Segers H, Van den Bos C, Van der Sluis IM, Tissing WJE, Veening MA, Zwaan CM, Van Tilburg CM, Pieters R, Bierings M. Thus KA, et al. Among authors: de groot kruseman ha. Haematologica. 2025 Jan 1;110(1):47-54. doi: 10.3324/haematol.2024.285428. Haematologica. 2025. PMID: 39113674 Free PMC article. Clinical Trial.

3

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.

Koedijk JB, van der Werf I, Penter L, Vermeulen MA, Barneh F, Perzolli A, Meesters-Ensing JI, Metselaar DS, Margaritis T, Fiocco M, de Groot-Kruseman HA, Moeniralam R, Bang Christensen K, Porter B, Pfaff K, Garcia JS, Rodig SJ, Wu CJ, Hasle H, Nierkens S, Belderbos ME, Zwaan CM, Heidenreich O. Koedijk JB, et al. Among authors: de groot kruseman ha. Leukemia. 2024 Nov;38(11):2332-2343. doi: 10.1038/s41375-024-02381-w. Epub 2024 Aug 26. Leukemia. 2024. PMID: 39187578 Free PMC article.

4

Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups.

Pieters R, de Groot-Kruseman H, Fiocco M, Verwer F, Van Overveld M, Sonneveld E, van der Velden V, Beverloo HB, Bierings M, Dors N, de Haas V, Hoogerbrugge P, Van der Sluis I, Tissing W, Veening M, Boer J, Den Boer M. Pieters R, et al. J Clin Oncol. 2023 Sep 1;41(25):4130-4142. doi: 10.1200/JCO.22.02705. Epub 2023 Jul 17. J Clin Oncol. 2023. PMID: 37459571

5

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

van Weelderen RE, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, Aplenc R, Arad-Cohen N, Bart-Delabesse E, Buldini B, De Moerloose B, Dworzak MN, Elitzur S, Fernández Navarro JM, Gamis A, Gerbing RB, Goemans BF, de Groot-Kruseman HA, Guest E, Ha SY, Hasle H, Kelaidi C, Lapillonne H, Leverger G, Locatelli F, Miyamura T, Norén-Nyström U, Polychronopoulou S, Rasche M, Rubnitz JE, Stary J, Tierens A, Tomizawa D, Zwaan CM, Kaspers GJL. van Weelderen RE, et al. Among authors: de groot kruseman ha. Blood Adv. 2024 Jun 25;8(12):3200-3213. doi: 10.1182/bloodadvances.2023011771. Blood Adv. 2024. PMID: 38621200 Free PMC article.

6

Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.

van Outersterp I, Boer JM, van de Ven C, Reichert CEJ, Boeree A, Kruisinga B, de Groot-Kruseman HA, Escherich G, Sijs-Szabo A, Rijneveld AW, den Boer ML. van Outersterp I, et al. Among authors: de groot kruseman ha. Blood Adv. 2024 Apr 23;8(8):1835-1845. doi: 10.1182/bloodadvances.2023012162. Blood Adv. 2024. PMID: 38386975 Free PMC article.

7

Intragraft platelet-derived growth factor-alpha and transforming growth factor-beta1 during the development of accelerated graft vascular disease after clinical heart transplantation.

de Groot-Kruseman HA, Baan CC, Mol WM, Niesters HG, Maat AP, Balk AH, Weimar W. de Groot-Kruseman HA, et al. Transpl Immunol. 1999 Dec;7(4):201-5. doi: 10.1016/s0966-3274(99)80003-3. Transpl Immunol. 1999. PMID: 10638832

8

Cytokine profiles as marker for graft vascular disease after clinical heart transplantation.

van Besouw NM, Baan CC, Holweg CT, de Groot-Kruseman HA, Peeters AM, Balk AH, Weimar W. van Besouw NM, et al. Ann Transplant. 2000;5(2):61-7. Ann Transplant. 2000. PMID: 11217209 No abstract available.

9

Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.

de Groot-Kruseman HA, Baan CC, Loonen EH, Mol WM, Niesters HG, Maat AP, Balk AH, Weimar W. de Groot-Kruseman HA, et al. J Heart Lung Transplant. 2001 May;20(5):503-10. doi: 10.1016/s1053-2498(00)00325-9. J Heart Lung Transplant. 2001. PMID: 11343976

10

Cyclosporine A downregulates intragraft platelet-derived growth factor-alpha mRNA expression after clinical heart transplantation.

de Groot-Kruseman HA, Baan CC, Mol WM, Niesters HG, Maat AP, Balk AH, Weimar W. de Groot-Kruseman HA, et al. Transplant Proc. 2001 May;33(3):2241-3. doi: 10.1016/s0041-1345(01)01953-4. Transplant Proc. 2001. PMID: 11377515 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters